Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Twist Bioscience Corporation (TWST) Misses Q4 EPS by 11c
December 11, 2019 4:11 PM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.96), $0.11 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $15.7 million versus the consensus estimate of $14.06 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2020 revenue of $80-84 million, versus... More



